But at the doses used, the net effect on blood sugar is positive because the GLP-1 and GIP activity dominates, and the glucagon activation primarily drives fat burning rather than glucose release
doi: 10.2337/db10-0474 [DOI] [PMC free article] [PubMed] [Google Scholar] 114.Luo ZY, Li X, Chen CT, et al
Our medical weight loss programs pair physician-supervised semaglutide with lab work, dosing oversight, and ongoing support from licensed providers, so your plan is tailored to your health, not a one-size-fits-all protocol
This mechanism is independent of antioxidant status, meaning glutathione's cellular protection doesn't directly enhance GLP-1 signaling
The microdosing approaches some patients use may also be contributing to suboptimal results